On August 2, 2021, the USPTO issued its first Director review decisions subsequent to the Supreme Court decision in Arthrex and the PTO's implementation of an interim procedure whereby review of a PTAB final written decision in an inter partes, post-grant, or covered business method review may be initiated sua sponte by Director or requested by a party to a PTAB proceeding. The order in each of the cases (IPR2020-00081 and IPR2020-00320) denied the request for Director review and provided that "the PTAB's Final Written Decision in this case is the final decision of the agency."
0 Comments
Your comment will be posted after it is approved.
Leave a Reply. |
Disclaimer: The content in this blog is solely for informational purposes and does not constitute legal advice.
AuthorArchives
September 2021
Categories
All
|